W E E K LY

REPORT
Da te: 02/08/2020

ISSUE NO.17

JOIN IN OUR TELEGRAM CHANNEL - t.me/equity99

Equity99 research is also available on

www.equity99.com
Date: 02/08/2020

Weekly Report

NIFTY For next week, 11010 will act as

nearest support point, Breaking
this level with volume will take

CASH NIFTY to 10930---10890 levels. On

the upper side 11160 will act as a
strong hurdle zone. Cross over and
close above will take NIFTY to
11240-11310-11350 levels during
this week itself.

For next week, 21325 will act as

nearest support point, Breaking
this level with volume will take
BANK
NIFTY to 21050-20925 levels. On
the upper side 21975 will act as a
strong hurdle zone. Cross over and
NIFTY
close above will take NIFTY to
22175-22400 levels during this
week itself.

JOIN IN OUR TELEGRAM CHANNEL - t.me/equity99

Date: 02/08/2020

Weekly Report

LAST WEEKS PERFORMANCE

Fantastic Performance
Of Last Week’s Weekly News Letter

CSB BANK recommended at 193 reached 204

OIL INDIA recommended at 96 reached at 99.9

MARICO recommended at 345 reached 368.9

GMR INFRA recommended at 21 reached 24.05

IDFC FIRST BANK recommended at 27 reached 29.2

JOIN IN OUR TELEGRAM CHANNEL - t.me/equity99

Date: 02/08/2020
Weekly Report
STOCKS FOR THIS WEEK
CADILA
HEALTHCARE
CMP: RS. 388.40
BSE: 532321 | NSE: CADILAHC BSE: 533150 | NSE: GODREJPROP
SECTOR: PHARMACEUTICALS
Stock is looking
highly explosive
on chart. Posi-
�onal traders can
watch on dips
around Rs.388-
380 with a stop
loss of Rs.367. On
the upper side we
are expec�ng
Rs.410-425 levels
in the next 10-15
days.
GODREJ BALKRISHNA
PROPERTIES INDUSTRIES
CMP: RS. 926.60 CMP: RS. 1322.05
BSE: 502355 | NSE: BALKRISIND
SECTOR: CONSTRUCTION & SECTOR: TYRES
CONTRACTING - REAL ESTATE
Stock is looking Stock is s�ll look-
highly explosive ing superb on
on chart. Posi- chart. Posi�onal
�onal traders can traders can watch
watch between between
Rs.925-900 with a Rs.1320-1290
stop loss of with a stop loss
Rs.885. On the of Rs.1260. On
upper side we are the upper side
expec�ng we are expec�ng
Rs.990-1010 Rs.1355-1400-
levels in the next 1415 levels in the
10-15 days. next 10-15 days.
JOIN IN OUR TELEGRAM CHANNEL - t.me/equity99
Date: 02/08/2020

Weekly Report

STOCKS FOR THIS WEEK

INDOCO SUDARSHAN
REMEDIES CHEMICALS
CMP: RS. 226.55 CMP: RS. 409.35
BSE: 532612 | NSE: INDOCO BSE: 506655 | NSE: SUDARSCHEM
SECTOR: PHARMACEUTICALS SECTOR: DYES & PIGMENTS

Stock is ready for a big One can watch for

up move a�er long posi�onal trading on
consolida�on. One can dips between Rs.407-
watch for posi�onal 400 with a stop loss
trading on dips be- of Rs.392. On the
tween Rs.225-218 with upper side we are
a stop loss of Rs.210. expec�ng Rs.440-450
On the upper side we levels in the next
are expec�ng Rs.250- 10-15 days.
265 levels in the next
1 month.

JOIN IN OUR TELEGRAM CHANNEL - t.me/equity99

Date: 02/08/2020

Weekly Report

DISCLOSURE & DISCLAIMER

Disclosure:
Authors and the names subscribed to this report, hereby cer�fy that all of the views expressed in this research report accurately reflect
our views about the subject issuer(s) or securi�es. We also cer�fy that no part of our compensa�on was, is, or will be directly or
indirectly related to the specific recommenda�on(s) or view(s) in this report. Research Analyst or his/her rela�ve or Equity99 Ltd. does
not have any financial interest in the subject company. Also Research Analyst or his/her rela�ve or Equity99 Ltd. or its Associate may
have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publica�on
of the Research Report. Further Research Analyst or his/her rela�ve or Equity99 Ltd. or its associate does not have any material conflict
of interest. Any holding in stock – No.

Disclaimer:
This report has been prepared by Equity99 Ltd. and is meant for sole use by the recipient and not for circula�on. The informa�on and
opinions contained herein have been compiled or arrived at, based upon informa�on obtained in good faith from sources believed to
be reliable. Such informa�on has not been independently verified and no guaranty, representa�on of warranty, express or implied, is
made as to its accuracy, completeness or correctness. All such informa�on and opinions are subject to change without no�ce. This
document is for informa�on purposes only. Descrip�ons of any company or companies or their securi�es men�oned herein are not
intended to be complete and this document is not, and should not be construed as an offer or solicita�on of an offer, to buy or sell any
securi�es or other financial instruments. This report is not directed to, or intended for display, downloading, prin�ng, reproducing or for
distribu�on to or use by, any person or en�ty who is a ci�zen or resident or located in any locality, state, country or other jurisdic�on
where such distribu�on, publica�on, reproduc�on, availability or use would be contrary to law or regula�on or what would subject
Equity99 Ltd. or its affiliates to any registra�on or licensing requirement within such jurisdic�on. If this report is inadvertently send or
has reached any individual in such country, especially, USA, the same may be ignored and brought to the a�en�on of the sender. This
document may not be reproduced, distributed or published for any purposes without prior wri�en approval of Equity99 Ltd. Foreign
currencies denominated securi�es, wherever men�oned, are subject to exchange rate fluctua�ons, which could have an adverse effect
on their value or price, or the income derived from them. In addi�on, investors in securi�es such as ADRs, the values of which are
influenced by foreign currencies effec�vely assume currency risk. It should not be considered to be taken as an offer to sell or a solicita-
�on to buy any security. Equity99 Ltd. may from �me to �me solicit from, or perform broking, or other services for, any company
men�oned in this mail and/or its a�achments. Equity99 Ltd. and its affiliated company(ies), their directors, analysts and employees
may; (a) from �me to �me, have a long or short posi�on in, and buy or sell the securi�es of the company(ies) men�oned herein or (b)
be engaged in any other transac�on involving such securi�es and earn brokerage or other compensa�on or act as a market maker in the
financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have
any other poten�al conflict of interests with respect to any recommenda�on and other related informa�on and opinions. Equity99 Ltd.,
its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to
the investments made or any ac�on taken on basis of this report, including but not restricted to, fluctua�on in the prices of shares and
bonds, changes in the currency rates, diminu�on in the NAVs, reduc�on in the dividend or income, etc. Equity99 Ltd. or its associates
might have managed or co-managed public offering of securi�es for the subject company or might have been mandated by the subject
company for any other assignment in the past twelve months. Equity99 Ltd. or its associates might have received any compensa�on
from the companies men�oned in the report during the period preceding twelve months from the date of this report for services in
respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services
or other advisory service in a merger or specific transac�on in the normal course of business. Equity99 Ltd. or its analysts did not receive
any compensa�on or other benefits from the companies men�oned in the report or third party in connec�on with prepara�on of the
research report. Accordingly, neither Equity99 Ltd. nor Research Analysts have any material conflict of interest at the �me of publica�on
of this report. Compensa�on of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage
service transac�ons. Equity99 Ltd. may have issued other reports that are inconsistent with and reach different conclusion from the
informa�on presented in this report. Research en�ty has not been engaged in market making ac�vity for the subject company. Research
analyst has not served as an officer, director or employee of the subject company.

JOIN IN OUR TELEGRAM CHANNEL - t.me/equity99